Benzethonium Chloride Finished Formula Data Support Antiseptic Use – Lonza
This article was originally published in The Tan Sheet
Executive Summary
Safety and efficacy studies on the use of benzethonium chloride in finished-product formulas bear out a Category I classification in the healthcare antiseptic monograph, chemical ingredient supplier Lonza says in a May 15 citizen petition to FDA
You may also be interested in...
ANDA Bioequivalence Data Subject Of Upcoming FDA Proposed Rule
FDA expects to issue an advance notice of proposed rulemaking in November requiring ANDA applicants to include data from all bioequivalence studies conducted on a drug formulation with their application
Benzethonium Chloride Review Prior To Final Monograph Urged By Lonza
A safety review of benzethonium chloride as a Category I active ingredient in the healthcare antiseptic products monograph should be conducted by FDA before completing the rule, chemical ingredient supplier Lonza suggests.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC